MyFinsight
Home
Blog
About
Contact
Cash and cash
equivalents
$262,518K
Short-term investments
$110,904K
Prepaid and other
current assets
$7,141K
Total current assets
$380,563K
Goodwill
$19,918K
Other non-current
assets
$812K
Total assets
$401,293K
Total liabilities and
shareholders' equity
$401,293K
Total shareholders'
equity
$278,849K
Total liabilities
$122,444K
Accumulated deficit
-$659,770K
Additional paid-in capital
$937,795K
Total current
liabilities
$81,112K
Credit facility,
long-term
$40,773K
Other non-current
liabilities
$559K
Accumulated other
comprehensive income
$824K
2022 usd financing
warrants
$49,471K
Accrued expenses
$24,514K
Accounts payable
$7,127K
Back
Back
Balance Sheet
Definium Therapeutics, Inc. (DFTX)
Definium Therapeutics, Inc. (DFTX)
source: myfinsight.com